Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2000
03/02/2000WO2000010595A2 Medicaments for manipulating t-cell immune response
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010549A1 Regulation of substrate activity
03/02/2000WO2000010548A2 19-nor-vitamin d3 compounds with calcemic activity
03/02/2000WO2000010545A2 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
03/02/2000WO2000010526A2 New oral formulation for 5-ht4 agonists or antagonists
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999058558A3 Cell signaling proteins
03/02/2000WO1999058555A3 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
03/02/2000WO1999045031A3 Cd147 binding molecules as therapeutics
03/02/2000WO1999011605A8 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
03/02/2000WO1998051662A3 Compounds and methods for the inhibition of the expression of vcam-1
03/02/2000DE19839499A1 2-Oxo-2H-chinolinderivate 2-oxo-2H-quinoline
03/02/2000DE19839337A1 Parenteral medicament for treating antithrombin III deficiency contains potent beta-isoform of antithrombin III
03/02/2000CA2342503A1 Quinazoline derivatives
03/02/2000CA2342162A1 Drug targeting
03/02/2000CA2341989A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341357A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000CA2341309A1 Use of mcrp for delivery of materials into cells
03/02/2000CA2341028A1 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000CA2340928A1 Novel arylsulphonamides and analogues
03/02/2000CA2340785A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000CA2340616A1 Secreted proteins and polynucleotides encoding them
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2339537A1 Regulation of substrate activity
03/02/2000CA2339372A1 New compounds
03/02/2000CA2339036A1 Tpl-2/cot kinase and methods of use
03/01/2000EP0982400A1 Human glycine transporter
03/01/2000EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
03/01/2000EP0982297A2 Process for the preparation of hydroxy-pyrrolidinyl hydroxamic acid derivatives being opioid kappa receptor agonists
03/01/2000EP0982025A1 Synthetic tear fluid
03/01/2000EP0981615A1 Protein kinase c inhibitor-like protein (ipkc-2)
03/01/2000EP0981550A1 Methods for eosinophil depletion and compositions therefor
03/01/2000EP0981547A1 Tumor-associated antigen
03/01/2000EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors
03/01/2000EP0981374A2 Sustained-release delayed gels
03/01/2000EP0981360A1 Method for preventing gastritis using amylin or amylin agonists
03/01/2000EP0981355A1 Treatment of chronic inflammatory diseases with cm101/gbs toxin
03/01/2000EP0981343A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
03/01/2000CN1246125A Peptides comprising a T-cell epitope specific to collagen II
03/01/2000CN1246124A 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
03/01/2000CN1246121A Immunosuppressive compounds and methods
03/01/2000CN1246111A Novel compound with analgesic effect
03/01/2000CN1246109A 5-aroylnaphthalene derivatives
03/01/2000CN1245799A Preparation method of pyrrolidyl hydroxamic acid compound
03/01/2000CN1049817C Method for preparation of percutaneously absorbable drug composition
03/01/2000CA2246791A1 Treatment of endothelium with somatostatin analogues
02/2000
02/29/2000US6031135 Protein kinase-c activity; antitumor agents, antiinflammatory agents, preservatives; treating thrombosis
02/29/2000US6031114 Process for pyrrolidinyl hydroxamic acid compounds
02/29/2000US6031080 Chemotactic cytokine
02/29/2000US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse;
02/29/2000US6030981 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
02/29/2000US6030946 Reversible cysteine protease inhibitors
02/29/2000US6030835 Methods and composition for identifying group a streptococcus
02/29/2000US6030834 Cdna (complementary dna) of human i kappa b kinase involved in activating transcription factors and causing inflammation; for drug screening of antiinflammatory agents
02/29/2000US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
02/29/2000US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01
02/29/2000US6030643 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
02/29/2000US6030612 Antimicrobial uses of multifunctional enzyme
02/29/2000CA2281050A1 Nitric oxide releasing oxindole prodrugs for analgesic, anti-inflammatory and disease-modifying use
02/29/2000CA2280049A1 Diarylsulfonylurea binding proteins
02/29/2000CA2117349C Benzopyrans and related ltb4 antagonists
02/28/2000CA2281055A1 Antithrombin iii-beta-comprising pharmaceutical preparation
02/28/2000CA2249037A1 Novel compounds
02/24/2000WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000WO2000009687A1 Novel gene and protein gmp30 encoded thereby
02/24/2000WO2000009552A1 Secreted proteins and polynucleotides encoding them
02/24/2000WO2000009511A1 Novel thiazolopyrimidine compounds
02/24/2000WO2000009510A1 Photocyclized rapamycins
02/24/2000WO2000009507A1 Phenyl yanthine derivatives
02/24/2000WO2000009504A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors
02/24/2000WO2000009503A1 Integrin receptor antagonists
02/24/2000WO2000009492A1 Tace inhibitors
02/24/2000WO2000009491A1 Calcilytic compounds
02/24/2000WO2000009168A1 A method of transducing mammalian cells, and products related thereto
02/24/2000WO2000009132A1 Calcilytic compounds
02/24/2000WO2000009130A2 New pharmaceutical uses for nos inhibitors
02/24/2000WO2000009129A1 C3a receptor ligands
02/24/2000WO2000009126A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
02/24/2000WO2000009117A1 Nimesulide containing topical pharmaceutical compositions
02/24/2000WO2000009109A2 Pipecolic acid derivatives for vision and memory disorders
02/24/2000WO2000009096A1 Injectable formulations of nanoparticulate naproxen
02/24/2000WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
02/24/2000WO2000009073A2 Blood-brain barrier therapeutics
02/24/2000WO1999057133A3 Inhibitors of nf-kb activation
02/24/2000WO1999048868A3 Heterocyclic classes of compounds for the modulating tyrosine protein kinase
02/24/2000WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same
02/24/2000WO1999045127A3 Enhanced prodrug activation
02/24/2000DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections
02/24/2000DE19837627A1 New aminoacid esters of arylsulfonamides are useful for e.g. treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections
02/24/2000CA2344520A1 Pipecolic acid derivatives for vision and memory disorders
02/24/2000CA2340700A1 Photocyclized rapamycins
02/24/2000CA2340418A1 Blood-brain barrier therapeutics
02/24/2000CA2340350A1 Phenyl yanthine derivatives
02/24/2000CA2340341A1 Calcilytic compounds
02/24/2000CA2340200A1 New pharmaceutical uses for nos inhibitors
1 ... 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 ... 1272